135 
DR. BROWN: I have Xeroxed my comments like others, and put it over 
there. It is a partial variorum of the particularly outstanding areas 
j disagree with. I could produce a full variorum edition, but I 
don't think you really want that. 
(Laughter. ) 
DR. FREDRICKSON: I would certainly not deny you any privilege that 
I have already given Dr. Goldstein if you wanted to work on that tonight. 
Now, Dr. McCarthy, all members of the committee will have received 
by the end of today the statements that have been filed? 
DR. MC CARTHY: I think they have them already. The only one I do 
not have is Dr. Sedat, who told me that he will get his text into us 
several days after the meeting. 
DR. FREDRICKSON: All right. He is not speaking until tomorrow, 
per his request. 
DR. MC CARTHY: I don't expect to have his even by tomorrow. 
DR. FREDRICKSON: Therefore we have a partial statement for the 
record and available to you of what Dr. Brown was earlier referring 
to, and now, it is his turn. 
SPEAKER: We do not have Dr. Brown's statement. 
DR. FREDRICKSON: Then we shall see that you get it — 
(Administrative discussion) 
DR. FREDRICKSON: Dr. Donald Brown is from the Carnegie Institution 
in Baltimore. Dr. Brown? 
DR. BROWN: Thank you very much for the invitation to come down and 
participate. I have a number of things to say, and I couldn't possibly 
say them all in 10 minutes. I thought perhaps I would just limit my 
comments to three different areas. One is the nature of the hazard as I 
have seen it and some of my colleagues. Second is my own history of 
Asilomar, which agrees to some extent with the last speaker who was here. 
And finally, some views, which the last speaker also mentioned, of perhaps 
how this process of examining hazards might be dealt with in a more 
effective and — in a way which everyone would agree with in the future. 
I am a biologist who has worked on gene purification for a number of 
years, and it was in fact the frog genes that we purified which were first 
[ 276 ] 
